Exablate Clinical Trials
2 recruitingDevice
Phase 12Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
Brain Tumor
InSightec10 enrolled3 locationsNCT05630209
Recruiting
Phase 1Phase 2
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG
Brain Tumor
InSightec10 enrolled1 locationNCT05615623